We use cookies to collect anonymous data to help us improve your site browsing experience.

Click 'Accept all cookies' to agree to all cookies that collect anonymous data. To only allow the cookies that make the site work, click 'Use essential cookies only.' Visit 'Set cookie preferences' to control specific cookies.

Set cookie preferences

Your cookie preferences have been saved. You can change your cookie settings at any time.

Publication - Advice and guidance

Coronavirus (COVID-19) AstraZeneca vaccine (ChAdOx1-S [Recombinant]): national protocol v3.0

Published 21 January 2022
From
Cabinet Secretary for Health and Social Care
Directorate
Health Performance and Delivery Directorate, +2 more … Chief Medical Officer Directorate, Covid Co-ordination Directorate
Part of
Coronavirus in Scotland, Health and social care, Public safety and emergencies
ISBN
9781802018059

This protocol is for the supply and administration of AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) to individuals in accordance with the national COVID-19 vaccination programme. This protocol only allows supply and administration during or in anticipation of the COVID-19 pandemic.

This document is part of a collection

View supporting documents Supporting documents

AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) Vaccine National Protocol

Reference no: AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) Vaccine Protocol

Version no: v 3.0

Valid from: 02 February 2021

Review date: 30 November 2021

Expiry date: 31 December 2021

Contact

Email: vaccineoperationaloversight@gov.scot

Back to top